Second, while we focused on cytokine and T cell profiling, our study did not assess clinically relevant biomarkers of human IBD (e.g., fecal calprotectin, serum CRP, or IL-6), limiting direct translational relevance. The gene discussed is IL6; the disease is inflammatory bowel disease.